These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26941095)

  • 1. Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction.
    Shi XL; Mancham S; Hansen BE; de Knegt RJ; de Jonge J; van der Laan LJ; Rivadeneira F; Metselaar HJ; Kwekkeboom J
    J Hepatol; 2016 Jun; 64(6):1274-82. PubMed ID: 26941095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.
    Forconi C; Gatault P; Miquelestorena-Standley E; Noble J; Al-Hajj S; Guillemain R; Stern M; Hoffmann T; Prat L; Suberbielle C; Masson E; Cesbron-Gautier A; Gaudy-Graffin C; Goudeau A; Thibault G; Ivanes F; Guibon R; Kazma I; Lebranchu Y; Büchler M; Magnan A; Halimi JM; Baron C
    J Heart Lung Transplant; 2017 Mar; 36(3):315-324. PubMed ID: 27751774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the Possible Association between PD-1 (Rs11568821, Rs2227981, Rs2227982) and PD-L1 (Rs4143815, Rs2890658) Polymorphisms and Susceptibility to Breast Cancer in a Sample of Southeast Iranian Women.
    Karami S; Sattarifard H; Kiumarsi M; Sarabandi S; Taheri M; Hashemi M; Bahari G; Ghavami S
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):3115-3123. PubMed ID: 33112575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer.
    Tan D; Sheng L; Yi QH
    Cancer Biomark; 2018 Feb; 21(2):287-297. PubMed ID: 29171986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival.
    Shen L; Jin Y; Freeman GJ; Sharpe AH; Dana MR
    J Immunol; 2007 Sep; 179(6):3672-9. PubMed ID: 17785803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascularized composite allograft rejection is delayed by infusion of IFN-γ-conditioned BMSCs through upregulating PD-L1.
    Wang Y; Xi Y; Han F; Liu Y; Li N; Ren Z; Xue J; Guo L; Hu D
    Cell Tissue Res; 2019 May; 376(2):211-220. PubMed ID: 30613905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
    Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
    Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of PD-L1 gene rs4143815 C>G polymorphism and human cancer susceptibility: A systematic review and meta-analysis.
    Zou J; Wu D; Li T; Wang X; Liu Y; Tan S
    Pathol Res Pract; 2019 Feb; 215(2):229-234. PubMed ID: 30552042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of programmed cell death 1 and programmed cell death 1 ligand gene polymorphisms with delayed graft function and acute rejection in kidney allograft recipients.
    Zolfaghari L; Solgi G; Nafar M; Ahmadpour P; Lassanpezeshki M; Ali Amirzargar M; Sharbafi MH; Pourrezagholi F; Samadian F; Parvin M; Razeghi E; Nicknam MH; Ghodssi-Ghasemabadi R; Amirzargar A
    Iran J Kidney Dis; 2015 Mar; 9(2):138-45. PubMed ID: 25851293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-1/PD-L1 costimulatory pathway-induced mouse islet transplantation immune tolerance.
    Li T; Ma R; Zhu JY; Wang FS; Huang L; Leng XS
    Transplant Proc; 2015; 47(1):165-70. PubMed ID: 25645798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow mesenchymal stromal cells attenuate liver allograft rejection may via upregulation PD-L1 expression through downregulation of miR-17-5p.
    Chen Q; Zhou R; Zhang Y; Zhu S; Xiao C; Gong J; Li K; Tang H; Sun C; Zhang J
    Transpl Immunol; 2018 Dec; 51():21-29. PubMed ID: 30092337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors.
    Seifert AM; Zeng S; Zhang JQ; Kim TS; Cohen NA; Beckman MJ; Medina BD; Maltbaek JH; Loo JK; Crawley MH; Rossi F; Besmer P; Antonescu CR; DeMatteo RP
    Clin Cancer Res; 2017 Jan; 23(2):454-465. PubMed ID: 27470968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population.
    Xie Q; Chen Z; Xia L; Zhao Q; Yu H; Yang Z
    Gene; 2018 Oct; 674():188-194. PubMed ID: 29940275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection.
    Li T; Ma R; Zhu J; Wang F; Huang L; Leng X
    Chin Med J (Engl); 2014; 127(14):2686-92. PubMed ID: 25043090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1.
    Patera AC; Drewry AM; Chang K; Beiter ER; Osborne D; Hotchkiss RS
    J Leukoc Biol; 2016 Dec; 100(6):1239-1254. PubMed ID: 27671246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Checkpoints Expression in Chronic Lung Allograft Rejection.
    Righi I; Vaira V; Morlacchi LC; Croci GA; Rossetti V; Blasi F; Ferrero S; Nosotti M; Rosso L; Clerici M
    Front Immunol; 2021; 12():714132. PubMed ID: 34489963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced T-cell immunity to osteosarcoma through antibody blockade of PD-1/PD-L1 interactions.
    Lussier DM; O'Neill L; Nieves LM; McAfee MS; Holechek SA; Collins AW; Dickman P; Jacobsen J; Hingorani P; Blattman JN
    J Immunother; 2015 Apr; 38(3):96-106. PubMed ID: 25751499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade or deficiency of PD-L1 expression in intestinal allograft accelerates graft tissue injury in mice.
    Matsushima H; Morita-Nakagawa M; Datta S; Pavicic PG; Hamilton TA; Abu-Elmagd K; Fujiki M; Osman M; D'Amico G; Eguchi S; Hashimoto K
    Am J Transplant; 2022 Mar; 22(3):955-965. PubMed ID: 34679256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of genetic variation in co-stimulatory molecule genes with outcome of liver transplant in Iranian patients.
    Karimi MH; Motazedian M; Abedi F; Yaghobi R; Geramizadeh B; Nikeghbalian S
    Gene; 2012 Aug; 504(1):127-32. PubMed ID: 22579879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.